_id
6919ec1f3c536f8df23183c8
Ticker
OBD.LSE
Name
Oxford Biodynamics PLC
Exchange
LSE
Address
3140 Rowan Place, Oxford, United Kingdom, OX4 2WB
Country
UK
Sector
Healthcare
Industry
Diagnostics & Research
Currency
GBX
Website
https://www.oxfordbiodynamics.com
Description
Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom. The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor immunotherapy. EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation and monitoring of 3D genomic biomarker. Its products include EpiSwitch Prostate Screening Test (PSE), a prostate cancer screening test; EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a blood test for predicting therapeutic response to checkpoint inhibitor immunotherapy; EpiSwitch Orion, a cloud platform, running on google cloud architecture; and EpiSwitch Explorer Array Kit platform, enabling advanced analysis of 3D regulatory control points. The company was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.
Last Close
2250
Volume
201000
Current Price
0.255
Change
0
Last Updated
2025-12-30T11:19:27.997Z
Image
https://logo.clearbit.com/www.oxfordbiodynamics.com
Ipo Date
-
Market Cap
9654550
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
508000
Cost Of Revenue
3580000
Gross Profit
-3072000
Operating Expenses
1686000
Operating Income
-4758000
Interest Expense
205000
Pretax Income
-5530000
Net Income
-5402000
Eps
-0.002759532948711279
Dividends Per Share
-
Shares Outstanding
4290910967
Income Tax Expense
-128000
EBITDA
-4757000
Operating Margin
-936.6141732283464
Total Other Income Expense Net
-772000
Cash
1392000
Short Term Investments
-
Receivables
694000
Inventories
195000
Total Current Assets
2281000
Property Plant Equipment
4699000
Total Assets
8086000
Payables
1318000
Short Term Debt
1288000
Long Term Debt
-
Total Liabilities
6970000
Equity
1116000
Bs_currency_symbol
GBP
Depreciation
568000
Change In Working Capital
711000
Cash From Operations
-2762000
Capital Expenditures
17000
Cash From Investing
-67000
Cash From Financing
-33000
Net Change In Cash
-2869000
Cf_currency_symbol
-
PE
-
PB
447.2959663575269
ROE
-484.0501792114695
ROA
-66.80682661390057
FCF
-2779000
Fcf Percent
-5.4704724409448815
Piotroski FScore
1
Health Score
9
Deep Value Investing Score
2
Defensive Investing Score
4.5
Dividend Investing Score
1
Economic Moat Investing Score
2.8
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
2
Net Net Investing Score
1
Quality Investing Score
1
Value Investing Score
1.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
508000
Quarters > 0 > income Statement > cost Of Revenue
3580000
Quarters > 0 > income Statement > gross Profit
-3072000
Quarters > 0 > income Statement > operating Expenses
1686000
Quarters > 0 > income Statement > operating Income
-4758000
Quarters > 0 > income Statement > interest Expense
205000
Quarters > 0 > income Statement > pretax Income
-5530000
Quarters > 0 > income Statement > net Income
-5402000
Quarters > 0 > income Statement > eps
-0.002759532948711279
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1957577641
Quarters > 0 > income Statement > income Tax Expense
-128000
Quarters > 0 > income Statement > EBITDA
-4757000
Quarters > 0 > income Statement > operating Margin
-936.6141732283464
Quarters > 0 > income Statement > total Other Income Expense Net
-772000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
1392000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
694000
Quarters > 0 > balance Sheet > inventories
195000
Quarters > 0 > balance Sheet > total Current Assets
2281000
Quarters > 0 > balance Sheet > property Plant Equipment
4699000
Quarters > 0 > balance Sheet > total Assets
8086000
Quarters > 0 > balance Sheet > payables
1318000
Quarters > 0 > balance Sheet > short Term Debt
1288000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
6970000
Quarters > 0 > balance Sheet > equity
1116000
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-5402000
Quarters > 0 > cash Flow > depreciation
568000
Quarters > 0 > cash Flow > change In Working Capital
711000
Quarters > 0 > cash Flow > cash From Operations
-2762000
Quarters > 0 > cash Flow > capital Expenditures
17000
Quarters > 0 > cash Flow > cash From Investing
-67000
Quarters > 0 > cash Flow > cash From Financing
-33000
Quarters > 0 > cash Flow > net Change In Cash
-2869000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.002759532948711279
Quarters > 0 > ratios > PB
447.2959663575269
Quarters > 0 > ratios > ROE
-484.0501792114695
Quarters > 0 > ratios > ROA
-66.80682661390057
Quarters > 0 > ratios > FCF
-2779000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-5.4704724409448815
Quarters > 0 > health Score
9
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
587000
Quarters > 1 > income Statement > cost Of Revenue
3664000
Quarters > 1 > income Statement > gross Profit
-3077000
Quarters > 1 > income Statement > operating Expenses
2828000
Quarters > 1 > income Statement > operating Income
-5905000
Quarters > 1 > income Statement > interest Expense
217000
Quarters > 1 > income Statement > pretax Income
-5892000
Quarters > 1 > income Statement > net Income
-5751000
Quarters > 1 > income Statement > eps
-0.006759741612796819
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
850772164
Quarters > 1 > income Statement > income Tax Expense
-141000
Quarters > 1 > income Statement > EBITDA
-5044000
Quarters > 1 > income Statement > operating Margin
-1005.962521294719
Quarters > 1 > income Statement > total Other Income Expense Net
13000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
4261000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
2104000
Quarters > 1 > balance Sheet > inventories
289000
Quarters > 1 > balance Sheet > total Current Assets
6654000
Quarters > 1 > balance Sheet > property Plant Equipment
5208000
Quarters > 1 > balance Sheet > total Assets
13302000
Quarters > 1 > balance Sheet > payables
1717000
Quarters > 1 > balance Sheet > short Term Debt
852000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
7374000
Quarters > 1 > balance Sheet > equity
5928000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
-5751000
Quarters > 1 > cash Flow > depreciation
631000
Quarters > 1 > cash Flow > change In Working Capital
187000
Quarters > 1 > cash Flow > cash From Operations
-4947000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
823000
Quarters > 1 > cash Flow > cash From Financing
6551000
Quarters > 1 > cash Flow > net Change In Cash
2434000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.006759741612796819
Quarters > 1 > ratios > PB
36.5969807388664
Quarters > 1 > ratios > ROE
-97.01417004048582
Quarters > 1 > ratios > ROA
-43.234100135318
Quarters > 1 > ratios > FCF
-4947000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-8.427597955706984
Quarters > 1 > health Score
17
Quarters > 2 > quarter
2024-09-30
Quarters > 2 > income Statement > revenue
309000
Quarters > 2 > income Statement > cost Of Revenue
3625000
Quarters > 2 > income Statement > gross Profit
-3316000
Quarters > 2 > income Statement > operating Expenses
10658000
Quarters > 2 > income Statement > operating Income
-6079000
Quarters > 2 > income Statement > interest Expense
406000
Quarters > 2 > income Statement > pretax Income
-7081000
Quarters > 2 > income Statement > net Income
-6842000
Quarters > 2 > income Statement > eps
-0.021939637777927064
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
311855650
Quarters > 2 > income Statement > income Tax Expense
-239000
Quarters > 2 > income Statement > EBITDA
-5935000
Quarters > 2 > income Statement > operating Margin
-1967.3139158576053
Quarters > 2 > income Statement > total Other Income Expense Net
-1002000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
1827000
Quarters > 2 > balance Sheet > short Term Investments
1000000
Quarters > 2 > balance Sheet > receivables
1385000
Quarters > 2 > balance Sheet > inventories
321000
Quarters > 2 > balance Sheet > total Current Assets
5046000
Quarters > 2 > balance Sheet > property Plant Equipment
5711000
Quarters > 2 > balance Sheet > total Assets
12108000
Quarters > 2 > balance Sheet > payables
953000
Quarters > 2 > balance Sheet > short Term Debt
2092000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
7750000
Quarters > 2 > balance Sheet > equity
4358000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-6842000
Quarters > 2 > cash Flow > depreciation
740000
Quarters > 2 > cash Flow > change In Working Capital
-1423000
Quarters > 2 > cash Flow > cash From Operations
-6733000
Quarters > 2 > cash Flow > capital Expenditures
14000
Quarters > 2 > cash Flow > cash From Investing
-1303000
Quarters > 2 > cash Flow > cash From Financing
8688000
Quarters > 2 > cash Flow > net Change In Cash
640000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.021939637777927064
Quarters > 2 > ratios > PB
18.247634407985313
Quarters > 2 > ratios > ROE
-156.99862322166132
Quarters > 2 > ratios > ROA
-56.50809382226627
Quarters > 2 > ratios > FCF
-6747000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-21.83495145631068
Quarters > 2 > health Score
17
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
327000
Quarters > 3 > income Statement > cost Of Revenue
4197000
Quarters > 3 > income Statement > gross Profit
-3870000
Quarters > 3 > income Statement > operating Expenses
2525000
Quarters > 3 > income Statement > operating Income
-6395000
Quarters > 3 > income Statement > interest Expense
117000
Quarters > 3 > income Statement > pretax Income
-4875000
Quarters > 3 > income Statement > net Income
-4725000
Quarters > 3 > income Statement > eps
-0.023356007114363343
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
202303415
Quarters > 3 > income Statement > income Tax Expense
-150000
Quarters > 3 > income Statement > EBITDA
-4030000
Quarters > 3 > income Statement > operating Margin
-1955.65749235474
Quarters > 3 > income Statement > total Other Income Expense Net
1520000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
1187000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1156000
Quarters > 3 > balance Sheet > inventories
229000
Quarters > 3 > balance Sheet > total Current Assets
2572000
Quarters > 3 > balance Sheet > property Plant Equipment
6385000
Quarters > 3 > balance Sheet > total Assets
11066000
Quarters > 3 > balance Sheet > payables
2665000
Quarters > 3 > balance Sheet > short Term Debt
840000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
9444000
Quarters > 3 > balance Sheet > equity
1622000
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
-4725000
Quarters > 3 > cash Flow > depreciation
728000
Quarters > 3 > cash Flow > change In Working Capital
782000
Quarters > 3 > cash Flow > cash From Operations
-3554000
Quarters > 3 > cash Flow > capital Expenditures
292000
Quarters > 3 > cash Flow > cash From Investing
-292000
Quarters > 3 > cash Flow > cash From Financing
-209000
Quarters > 3 > cash Flow > net Change In Cash
-4063000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.023356007114363343
Quarters > 3 > ratios > PB
31.804790890875463
Quarters > 3 > ratios > ROE
-291.3070283600493
Quarters > 3 > ratios > ROA
-42.69835532260979
Quarters > 3 > ratios > FCF
-3846000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-11.761467889908257
Quarters > 3 > health Score
9
Annuals > 0 > quarter
2025-09-30
Annuals > 0 > income Statement > revenue
1095000
Annuals > 0 > income Statement > cost Of Revenue
7244000
Annuals > 0 > income Statement > gross Profit
-6149000
Annuals > 0 > income Statement > operating Expenses
4514000
Annuals > 0 > income Statement > operating Income
-10663000
Annuals > 0 > income Statement > interest Expense
422000
Annuals > 0 > income Statement > pretax Income
-11422000
Annuals > 0 > income Statement > net Income
-11153000
Annuals > 0 > income Statement > eps
-0.008040660222280444
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1387075152
Annuals > 0 > income Statement > income Tax Expense
-269000
Annuals > 0 > income Statement > EBITDA
-9801000
Annuals > 0 > income Statement > operating Margin
-973.7899543378995
Annuals > 0 > income Statement > total Other Income Expense Net
-759000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
1392000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
694000
Annuals > 0 > balance Sheet > inventories
195000
Annuals > 0 > balance Sheet > total Current Assets
2281000
Annuals > 0 > balance Sheet > property Plant Equipment
4699000
Annuals > 0 > balance Sheet > total Assets
8086000
Annuals > 0 > balance Sheet > payables
1318000
Annuals > 0 > balance Sheet > short Term Debt
1288000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
6970000
Annuals > 0 > balance Sheet > equity
1116000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-11153000
Annuals > 0 > cash Flow > depreciation
1199000
Annuals > 0 > cash Flow > change In Working Capital
898000
Annuals > 0 > cash Flow > cash From Operations
-7709000
Annuals > 0 > cash Flow > capital Expenditures
17000
Annuals > 0 > cash Flow > cash From Investing
756000
Annuals > 0 > cash Flow > cash From Financing
6518000
Annuals > 0 > cash Flow > net Change In Cash
-435000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.008040660222280444
Annuals > 0 > ratios > PB
278.4093495053764
Annuals > 0 > ratios > ROE
-999.3727598566308
Annuals > 0 > ratios > ROA
-137.92975513232747
Annuals > 0 > ratios > FCF
-7726000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-7.055707762557078
Annuals > 0 > health Score
9
Annuals > 1 > quarter
2024-09-30
Annuals > 1 > income Statement > revenue
636000
Annuals > 1 > income Statement > cost Of Revenue
347000
Annuals > 1 > income Statement > gross Profit
289000
Annuals > 1 > income Statement > operating Expenses
13183000
Annuals > 1 > income Statement > operating Income
-12894000
Annuals > 1 > income Statement > interest Expense
225000
Annuals > 1 > income Statement > pretax Income
-11956000
Annuals > 1 > income Statement > net Income
-11567000
Annuals > 1 > income Statement > eps
-0.045231495140152116
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
255728889
Annuals > 1 > income Statement > income Tax Expense
-389000
Annuals > 1 > income Statement > EBITDA
-10265000
Annuals > 1 > income Statement > operating Margin
-2027.3584905660377
Annuals > 1 > income Statement > total Other Income Expense Net
938000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
1827000
Annuals > 1 > balance Sheet > short Term Investments
1000000
Annuals > 1 > balance Sheet > receivables
1385000
Annuals > 1 > balance Sheet > inventories
321000
Annuals > 1 > balance Sheet > total Current Assets
5046000
Annuals > 1 > balance Sheet > property Plant Equipment
5711000
Annuals > 1 > balance Sheet > total Assets
12108000
Annuals > 1 > balance Sheet > payables
953000
Annuals > 1 > balance Sheet > short Term Debt
2092000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
7750000
Annuals > 1 > balance Sheet > equity
4358000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-11956000
Annuals > 1 > cash Flow > depreciation
1466000
Annuals > 1 > cash Flow > change In Working Capital
-641000
Annuals > 1 > cash Flow > cash From Operations
-10172000
Annuals > 1 > cash Flow > capital Expenditures
595000
Annuals > 1 > cash Flow > cash From Investing
-1485000
Annuals > 1 > cash Flow > cash From Financing
8254000
Annuals > 1 > cash Flow > net Change In Cash
-3423000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.045231495140152116
Annuals > 1 > ratios > PB
13.144394478201011
Annuals > 1 > ratios > ROE
-265.41991739329967
Annuals > 1 > ratios > ROA
-95.53187974892633
Annuals > 1 > ratios > FCF
-10767000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-16.92924528301887
Annuals > 1 > health Score
16
Annuals > 2 > quarter
2023-09-30
Annuals > 2 > income Statement > revenue
510000
Annuals > 2 > income Statement > cost Of Revenue
244000
Annuals > 2 > income Statement > gross Profit
266000
Annuals > 2 > income Statement > operating Expenses
10434000
Annuals > 2 > income Statement > operating Income
-11026000
Annuals > 2 > income Statement > interest Expense
213000
Annuals > 2 > income Statement > pretax Income
-11411000
Annuals > 2 > income Statement > net Income
-10826000
Annuals > 2 > income Statement > eps
-0.0734057841506782
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
147481566
Annuals > 2 > income Statement > income Tax Expense
-585000
Annuals > 2 > income Statement > EBITDA
-9841000
Annuals > 2 > income Statement > operating Margin
-2161.9607843137255
Annuals > 2 > income Statement > total Other Income Expense Net
-416000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
5250000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
1643000
Annuals > 2 > balance Sheet > inventories
274000
Annuals > 2 > balance Sheet > total Current Assets
7167000
Annuals > 2 > balance Sheet > property Plant Equipment
6997000
Annuals > 2 > balance Sheet > total Assets
16127000
Annuals > 2 > balance Sheet > payables
485000
Annuals > 2 > balance Sheet > short Term Debt
1636000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
10072000
Annuals > 2 > balance Sheet > equity
6055000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-10826000
Annuals > 2 > cash Flow > depreciation
1357000
Annuals > 2 > cash Flow > change In Working Capital
-671000
Annuals > 2 > cash Flow > cash From Operations
-8436000
Annuals > 2 > cash Flow > capital Expenditures
716000
Annuals > 2 > cash Flow > cash From Investing
-691000
Annuals > 2 > cash Flow > cash From Financing
13420000
Annuals > 2 > cash Flow > net Change In Cash
4276000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.0734057841506782
Annuals > 2 > ratios > PB
5.455965447398844
Annuals > 2 > ratios > ROE
-178.7943848059455
Annuals > 2 > ratios > ROA
-67.12965833695046
Annuals > 2 > ratios > FCF
-9152000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-17.945098039215686
Annuals > 2 > health Score
20
Annuals > 3 > quarter
2022-09-30
Annuals > 3 > income Statement > revenue
154000
Annuals > 3 > income Statement > cost Of Revenue
38000
Annuals > 3 > income Statement > gross Profit
116000
Annuals > 3 > income Statement > operating Expenses
8717000
Annuals > 3 > income Statement > operating Income
-8601000
Annuals > 3 > income Statement > interest Expense
195000
Annuals > 3 > income Statement > pretax Income
-7567000
Annuals > 3 > income Statement > net Income
-6710000
Annuals > 3 > income Statement > eps
-0.06730038217690498
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
99702257
Annuals > 3 > income Statement > income Tax Expense
-857000
Annuals > 3 > income Statement > EBITDA
-6159000
Annuals > 3 > income Statement > operating Margin
-5585.064935064935
Annuals > 3 > income Statement > total Other Income Expense Net
1034000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
974000
Annuals > 3 > balance Sheet > short Term Investments
25000
Annuals > 3 > balance Sheet > receivables
1429000
Annuals > 3 > balance Sheet > inventories
337000
Annuals > 3 > balance Sheet > total Current Assets
2765000
Annuals > 3 > balance Sheet > property Plant Equipment
6978000
Annuals > 3 > balance Sheet > total Assets
11344000
Annuals > 3 > balance Sheet > payables
857000
Annuals > 3 > balance Sheet > short Term Debt
1472000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
8756000
Annuals > 3 > balance Sheet > equity
2588000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-7567000
Annuals > 3 > cash Flow > depreciation
1213000
Annuals > 3 > cash Flow > change In Working Capital
999000
Annuals > 3 > cash Flow > cash From Operations
-5177000
Annuals > 3 > cash Flow > capital Expenditures
901000
Annuals > 3 > cash Flow > cash From Investing
1251000
Annuals > 3 > cash Flow > cash From Financing
2562000
Annuals > 3 > cash Flow > net Change In Cash
-1201000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-0.06730038217690498
Annuals > 3 > ratios > PB
8.629561656877899
Annuals > 3 > ratios > ROE
-259.27357032457496
Annuals > 3 > ratios > ROA
-59.15021156558533
Annuals > 3 > ratios > FCF
-6078000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-39.467532467532465
Annuals > 3 > health Score
8
Valuation > metrics > PE
-0.002759532948711279
Valuation > metrics > PB
447.2959663575269
Valuation > final Score
20
Valuation > verdict
14809.9% Overvalued
Profitability > metrics > ROE
-484.0501792114695
Profitability > metrics > ROA
-236.82595352915388
Profitability > metrics > Net Margin
-10.633858267716535
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
6.245519713261649
Risk > metrics > Interest Coverage
-23.209756097560977
Risk > final Score
-87
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.875287797390637
Liquidity > metrics > Quick Ratio
0.8004604758250192
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-79
Prev Risks > 1
-30
Prev Risks > 2
-213
Prev Liquidities > 0
100
Prev Liquidities > 1
91
Prev Liquidities > 2
43
Updated At
2026-01-20T23:03:07.072Z
Earnings History > 0 > period
2025-03-31
Earnings History > 0 > report Date
2025-06-30
Earnings History > 0 > date
2025-03-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.007
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.007
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-12-31
Earnings History > 1 > report Date
2025-03-05
Earnings History > 1 > date
2024-12-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.02
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.02
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2022-12-31
Earnings History > 2 > report Date
2023-01-24
Earnings History > 2 > date
2022-12-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
GBP
Earnings History > 2 > eps Actual
-0.04
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-03-31
Earnings History > 3 > report Date
2022-06-28
Earnings History > 3 > date
2022-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
GBP
Earnings History > 3 > eps Actual
-0.03
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2021-12-31
Earnings History > 4 > report Date
2022-01-26
Earnings History > 4 > date
2021-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
GBP
Earnings History > 4 > eps Actual
-0.04
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2021-03-31
Earnings History > 5 > report Date
2021-06-15
Earnings History > 5 > date
2021-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
GBP
Earnings History > 5 > eps Actual
-0.03
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2020-12-31
Earnings History > 6 > report Date
2021-01-28
Earnings History > 6 > date
2020-12-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
GBP
Earnings History > 6 > eps Actual
-0.02
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.02
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2020-03-31
Earnings History > 7 > report Date
2020-06-16
Earnings History > 7 > date
2020-03-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
GBP
Earnings History > 7 > eps Actual
-0.02
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.02
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-09-30
Earnings History > 8 > report Date
2019-12-10
Earnings History > 8 > date
2019-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
GBP
Earnings History > 8 > eps Actual
-0.02
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.02
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-03-31
Earnings History > 9 > report Date
2019-05-28
Earnings History > 9 > date
2019-03-31
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
GBP
Earnings History > 9 > eps Actual
-0.01
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.01
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2018-09-30
Earnings History > 10 > report Date
2018-12-11
Earnings History > 10 > date
2018-09-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
GBP
Earnings History > 10 > eps Actual
-0.01
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.01
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-03-31
Earnings History > 11 > report Date
2018-05-22
Earnings History > 11 > date
2018-03-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
GBP
Earnings History > 11 > eps Actual
-0.01
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.01
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2017-12-31
Earnings History > 12 > report Date
2018-01-30
Earnings History > 12 > date
2017-12-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
GBP
Earnings History > 12 > eps Actual
-0.01
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.01
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2017-03-31
Earnings History > 13 > report Date
2017-06-13
Earnings History > 13 > date
2017-03-31
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
GBP
Earnings History > 13 > eps Actual
-0.03
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.03
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2016-12-31
Earnings History > 14 > report Date
2017-01-31
Earnings History > 14 > date
2016-12-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
GBP
Earnings History > 14 > eps Actual
-0.01
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.01
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2016-09-30
Earnings History > 15 > report Date
2016-12-15
Earnings History > 15 > date
2016-09-30
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
GBP
Earnings History > 15 > eps Actual
-0.01
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.01
Earnings History > 15 > surprise Percent
-
Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom. The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor immunotherapy. EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation and monitoring of 3D genomic biomarker. Its products include EpiSwitch Prostate Screening Test (PSE), a prostate cancer screening test; EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a blood test for predicting therapeutic response to checkpoint inhibitor immunotherapy; EpiSwitch Orion, a cloud platform, running on google cloud architecture; and EpiSwitch Explorer Array Kit platform, enabling advanced analysis of 3D regulatory control points. The company was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AOxford BioDynamics - OBD and UEA develop test for Chronic Fatigue Research Tree
Read more →(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Oxford Biodynamics PLC
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-03-31
EPS Actual
-0.007
EPS Estimate
0
EPS Difference
-0.007
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-09-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.